Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 3/1998

01-03-1998 | Original Research Article

A Short Term Cost-Effectiveness Model For Oral Antidiabetic Medicines in Europe

Authors: Sheila C. Hood, Lieven Annemans, Maureen Rutten-van Mölken

Published in: PharmacoEconomics | Issue 3/1998

Login to get access
Metadata
Title
A Short Term Cost-Effectiveness Model For Oral Antidiabetic Medicines in Europe
Authors
Sheila C. Hood
Lieven Annemans
Maureen Rutten-van Mölken
Publication date
01-03-1998
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 3/1998
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-199813030-00006

Other articles of this Issue 3/1998

PharmacoEconomics 3/1998 Go to the issue

Current Opinion

The Pros and Cons of a Single ‘Euro—Price’ For Drugs

Adis Pharmacoeconomic Drug Evaluation

Meropenem

Review Article

The Economics of Parallel Trade

Leading Article

The Role of Cost—Consequence Analysis in Healthcare Decision—Making

Original Research Article

Average Annual Drug Cost and its Determinants in a Population Based Cohort of HIV—Positive Adult Men and Women

Original Research Article

Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness—To—Pay Approach